Evidence map›Paper›PMID 31374852›Full record

ReviewMolecules (Basel, Switzerland)2019

Galactosaminoglycans: Medical Applications and Drawbacks.

Vitor H Pomin, William P Vignovich, Alysia V Gonzales, Ariana A Vasconcelos, Barbara Mulloy

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Heterologous production of chondroitin.Biotechnology reports (Amsterdam, Netherlands) · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Vitor H PominDepartment of Biomolecular Sciences, School of Pharmacy, University of Mississippi, Oxford, MS 38677-1848, USA. vpomin@olemiss.edu.ORCID 0000-0002-5015-8880
William P VignovichDepartment of Biomolecular Sciences, School of Pharmacy, University of Mississippi, Oxford, MS 38677-1848, USA.
Alysia V GonzalesDepartment of Biomolecular Sciences, School of Pharmacy, University of Mississippi, Oxford, MS 38677-1848, USA.
Ariana A VasconcelosInstitute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941-590, Brazil.
Barbara MulloyImperial College, Department of Medicine, Burlington Danes Building, Du Cane Road, London W12 0NN, UK.
University of Mississippi · USImperial College London · GBUniversidade Federal do Rio de Janeiro · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Galactosaminoglycans (GalAGs) are sulfated glycans composed of alternating

Indexed as

AcetylgalactosamineArthralgiaChondroitin SulfatesHumansOsteoarthritisPolysaccharidesUronic AcidsAcetylgalactosamineChondroitin Sulfatesfucosylated chondroitin sulfategalactosaminoglycanPolysaccharidesUronic AcidsCarbohydrate-based drug discoverychondroitin sulfatedermatan sulfatefucosylated chondroitin sulfategalactosaminoglycans

Identifiers

PMID31374852
PMCPMC6696379
OpenAlexW2965451962

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.